Neutrophils are mediators of metastatic prostate cancer progression in bone is a research paper published in Cancer Immunology Immunotherapy (2020). On theSindex it has a DataRank of 0.628. It has been cited 65 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Base Score Contribution
0.628
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology βAmerican Cancer Society
Grant: PF-13-175-01-CSM
American Cancer Society
Grant: RSG-19-127-01-CSM
National Institutes of Health
Grant: R00HL123471
National Cancer Institute
Grant: P50CA97186
National Institute of Allergy and Infectious Diseases
Grant: P01 AI083211
NCI NIH HHS
Grant: P50 CA097186
National Institutes of Health
Grant: 5P50CA097186-13
Clinical Development of Therapeutic Strategies Targeting Damage Responses in the Prostate Tumor Microenvironment
National Institutes of Health
Grant: 2P01AI083211-06
Innate Immune Response to S. aureus biofilm
National Institutes of Health
Grant: 5R00HL123471-04
Redox Regulation of T-lymphocytes in Sympathoexcitation-associated Hypertension
National Institutes of Health
Grant: 3P30CA076292-24S2
Moffitt Cancer Center Support Grant
FWCI
3.02
Citation Percentile
0.9%
Influential Citations
3
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of IL4/IL4R signaling promotes the osteolysis in metastatic bone of CRC through regulating the proliferation of osteoclast precursors
Additional file 1 of IL4/IL4R signaling promotes the osteolysis in metastatic bone of CRC through regulating the proliferation of osteoclast precursors